Literature DB >> 11895093

Increase in meningococcal disease associated with the emergence of a novel ST-11 variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999-2000.

D E Tribe1, A M Zaia, J M Griffith, P M Robinson, H Y Li, K N Taylor, G G Hogg.   

Abstract

In the years 1999-2000, there was an increase in the incidence of meningococcal disease in Victoria, largely caused by Neisseria meningitidis serogroup C. This change was associated with a shift in age distribution of cases, with relatively more disease appearing in the 15-29 year age group, and with 40/58 serogroup C isolates in 2000 exhibiting a new macrorestriction pattern (pattern A). Thirty-four of 52 pattern A isolates tested displayed the novel phenotype C:2a:P1.4, and were consistently porA VR type P1.7-2,4 by DNA sequencing. Nine of 10 representative pattern A isolates analysed displayed a housekeeping gene allele profile (ST-11) that is characteristic of the electrophoretic type (ET)-15 variant that has caused outbreaks in Canada, the Czech Republic and Greece. Meningococci belonging to the ST-11 complex that were isolated in Victoria prior to 1999 did not display either restriction pattern A or PorA VR type P1.7-2,4.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895093      PMCID: PMC2869797          DOI: 10.1017/s0950268801006343

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Resolution of a meningococcal disease outbreak from whole-genome sequence data with rapid Web-based analysis methods.

Authors:  Keith A Jolley; Dorothea M C Hill; Holly B Bratcher; Odile B Harrison; Ian M Feavers; Julian Parkhill; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.

Authors:  Jessica R Macneil; Jennifer D Thomas; Amanda C Cohn
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

3.  IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone.

Authors:  Johannes Elias; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

4.  Epidemiology of meningococcal disease in Switzerland, 1999-2002.

Authors:  H Jaccard Ruedin; B Ninet; E Pagano; P Rohner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

5.  Australian public health policy in 2003 - 2004.

Authors:  Vivian Lin; Priscilla Robinson
Journal:  Aust New Zealand Health Policy       Date:  2005-04-06

6.  Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.

Authors:  Shakeel Mowlaboccus; Christopher A Mullally; Peter C Richmond; Benjamin P Howden; Kerrie Stevens; David J Speers; Anthony D Keil; Ottar N Bjørnstad; Timothy T Perkins; Charlene M Kahler
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

7.  Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing.

Authors:  Debora Ribeiro de Souza Santos; Kayo Bianco; Maysa Beatriz Mandetta Clementino; Alberto Martín Rivera Dávila; Ivano de Filippis
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-10-07       Impact factor: 2.747

8.  Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.

Authors:  Chien-Shun Chiou; Jui-Cheng Liao; Tsai-Ling Liao; Chun-Chin Li; Chen-Ying Chou; Hsiu-Li Chang; Shu-Man Yao; Yeong-Sheng Lee
Journal:  BMC Infect Dis       Date:  2006-02-15       Impact factor: 3.090

9.  A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

Authors:  Maria Jose Uria; Qian Zhang; Yanwen Li; Angel Chan; Rachel M Exley; Bridget Gollan; Hannah Chan; Ian Feavers; Andy Yarwood; Raquel Abad; Ray Borrow; Roland A Fleck; Barbara Mulloy; Julio A Vazquez; Christoph M Tang
Journal:  J Exp Med       Date:  2008-05-26       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.